Next Article in Journal
Human Coronavirus OC43 as a Low-Risk Model to Study COVID-19
Next Article in Special Issue
Real-World Study on Effectiveness of Molnupiravir and Nirmatrelvir–Ritonavir in Unvaccinated Patients with Chronic Respiratory Diseases with Confirmed SARS-CoV-2 Infection Managed in Out-Patient Setting
Previous Article in Journal
Introductions of Human-Origin Seasonal H3N2, H1N2 and Pre-2009 H1N1 Influenza Viruses to Swine in Brazil
Previous Article in Special Issue
Early Treatments of Fragile Children with COVID-19—Results of CLEVER (Children COVID Early Treatment), a Retrospective, Observational Study
 
 
Review

Article Versions Notes

Viruses 2023, 15(2), 577; https://doi.org/10.3390/v15020577
Action Date Notes Link
article xml file uploaded 20 February 2023 04:52 CET Original file -
article xml uploaded. 20 February 2023 04:52 CET Update -
article pdf uploaded. 20 February 2023 04:52 CET Version of Record https://www.mdpi.com/1999-4915/15/2/577/pdf-vor
article html file updated 20 February 2023 04:53 CET Original file -
article xml file uploaded 21 February 2023 09:40 CET Update -
article xml uploaded. 21 February 2023 09:40 CET Update https://www.mdpi.com/1999-4915/15/2/577/xml
article pdf uploaded. 21 February 2023 09:40 CET Updated version of record https://www.mdpi.com/1999-4915/15/2/577/pdf
article html file updated 21 February 2023 09:41 CET Update -
article html file updated 9 March 2023 21:15 CET Update https://www.mdpi.com/1999-4915/15/2/577/html
Back to TopTop